Does ibogaine show up on a drug test?

Why standard panels miss it

Routine drug tests screen for a fixed list of common drug classes: amphetamines, cannabis, cocaine, opioids, benzodiazepines, PCP and a handful of others. Ibogaine belongs to none of those classes. It is an indole alkaloid from the Tabernanthe iboga shrub, structurally unlike the substances immunoassay panels are built to catch, so it does not trigger them and does not cross-react with them. The same is true of noribogaine, the long-lasting metabolite your liver produces from ibogaine.

What can detect it

Ibogaine and noribogaine can be measured, but only when a lab is asked to look for them specifically, using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS). These are the same techniques used in the research literature to track blood levels during treatment. They are not part of any standard employment, court-ordered or clinical screen, and a lab does not report a substance it was not asked to test for.

A more useful question: what will it clear?

People usually ask this for one of two reasons, and the honest answer differs for each. If the worry is testing positive for ibogaine itself, you will not on a normal panel. If the hope is that ibogaine masks or flushes other drugs from a test, it does not. Ibogaine does not cleanse other substances from your system or shorten their detection windows. In fact, before treatment most clinics require you to be substantially clear of long-acting opioids and other drugs precisely because those substances interfere with the treatment and raise its risk.